AminNassarMD

Oncology • New Haven, CT

Medical Oncology fellow/Yale New Haven Hospital

Join to view full profile

Dr. Nassar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nassar's full profile

Already have an account?

Office
20 York St
New Haven, CT 06510
Phone+1 203-688-4242

Education & Training

Brigham and Women's HospitalResidency, Internal Medicine, 2019 - 2022
American University of Beirut Faculty of MedicineClass of 2017

Certifications & Licensure

CT State Medical License 2022 - 2025
MA State Medical License 2019 - 2022
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Alpha Omega Alpha Honor Society 2016

Publications & Presentations

PubMed

Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and L...
Kathryn Lurain, Talal El Zarif, Ramya Ramaswami, Amin H Nassar, Elio Adib
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01
Safety and Efficacy of Osimertinib in Patients With Non-Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and...
Jonathan N Priantti, Yu Fujiwara, Francisco Cezar Aquino de Moraes, Isabella Michelon, Caio Castro
JCO Precision Oncology. 2024-11-01
Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitations.
Ritujith Jayakrishnan, David J Kwiatkowski, Michal G Rose, Amin H Nassar
The Oncologist. 2024-10-03

Lectures

Circulating tumor (ct)-DNA alterations in patients with testicular germ tumors.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Immune Checkpoint Inhibitors for Patients Living with HIV: Safe and Effective in Metastatic NSCLCNovember 11th, 2022
Germline Variants Found in 18% of Patients with Familial UCMay 13th, 2019
Immune-Based Cancer Drugs Offer Hope Against Penile CancersAugust 16th, 2023
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

External Links

Google Scholarhttps://scholar.google.com/citations?user=820GTxUAAAAJ&hl=en